113 related articles for article (PubMed ID: 27633959)
1. Synthesis of IR-780 dye-conjugated abiraterone for prostate cancer imaging and therapy.
Yi X; Zhang J; Yan F; Lu Z; Huang J; Pan C; Yuan J; Zheng W; Zhang K; Wei D; He W; Yuan J
Int J Oncol; 2016 Nov; 49(5):1911-1920. PubMed ID: 27633959
[TBL] [Abstract][Full Text] [Related]
2. Small Mitochondria-Targeting Fluorophore with Multifunctional Therapeutic Activities against Prostate Cancer via the HIF1α/OATPs Pathway.
Qin J; Zhang C; Zhao Y; Tan D; Wu P; Shui X; Qin W; Ge X; Shi C
Mol Pharm; 2023 Dec; 20(12):6226-6236. PubMed ID: 37955533
[TBL] [Abstract][Full Text] [Related]
3. IR-780 dye for near-infrared fluorescence imaging in prostate cancer.
Yi X; Yan F; Wang F; Qin W; Wu G; Yang X; Shao C; Chung LW; Yuan J
Med Sci Monit; 2015 Feb; 21():511-7. PubMed ID: 25686161
[TBL] [Abstract][Full Text] [Related]
4. Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration.
Yang H; Zhou T; Cai W; Yi X; Liu X; Wang Y; Zhang L; Duan Y
Tumour Biol; 2016 Oct; 37(10):14153-14163. PubMed ID: 27539728
[TBL] [Abstract][Full Text] [Related]
5. The near-infrared fluorescent dye IR-780 was coupled with cabazitaxel for castration-resistant prostate cancer imaging and therapy.
Zheng Y; Hou G; Zhang G; Lan T; Yuan J; Zhang L; Yan F; Wang F; Meng P; Dun X; Li X; Chen G; Zhu Z; Wei D; He W; Yuan J
Invest New Drugs; 2020 Dec; 38(6):1641-1652. PubMed ID: 32361788
[TBL] [Abstract][Full Text] [Related]
6. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes.
Chen Q; Shang W; Zeng C; Wang K; Liang X; Chi C; Liang X; Yang J; Fang C; Tian J
Oncotarget; 2017 May; 8(20):32741-32751. PubMed ID: 28416757
[TBL] [Abstract][Full Text] [Related]
7. Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes.
Zhao N; Zhang C; Zhao Y; Bai B; An J; Zhang H; Wu JB; Shi C
Oncotarget; 2016 Aug; 7(35):57277-57289. PubMed ID: 27329598
[TBL] [Abstract][Full Text] [Related]
8. Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.
Li R; Evaul K; Sharma KK; Chang KH; Yoshimoto J; Liu J; Auchus RJ; Sharifi N
Clin Cancer Res; 2012 Jul; 18(13):3571-9. PubMed ID: 22753664
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugate.
Lv Q; Yang X; Wang M; Yang J; Qin Z; Kan Q; Zhang H; Wang Y; Wang D; He Z
J Control Release; 2018 Jun; 279():234-242. PubMed ID: 29679664
[TBL] [Abstract][Full Text] [Related]
10. Multifunction in One Molecule: Mitochondrial Imaging and Photothermal & Photodynamic Cytotoxicity of Fast-Response Near-Infrared Fluorescent Probes with Aggregation-Induced Emission Characteristics.
Zhang L; Wang JL; Ba XX; Hua SY; Jiang P; Jiang FL; Liu Y
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7945-7954. PubMed ID: 33588525
[TBL] [Abstract][Full Text] [Related]
11. A multifunctional heptamethine near-infrared dye for cancer theranosis.
Luo S; Tan X; Qi Q; Guo Q; Ran X; Zhang L; Zhang E; Liang Y; Weng L; Zheng H; Cheng T; Su Y; Shi C
Biomaterials; 2013 Mar; 34(9):2244-51. PubMed ID: 23261220
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Preclinical Evaluation of Small-Molecule Prostate-Specific Membrane Antigen-Targeted Abiraterone Conjugate.
Machulkin AE; Nimenko EA; Zyk NU; Uspenskaia AA; Smirnova GB; Khan II; Pokrovsky VS; Vaneev AN; Timoshenko RV; Mamed-Nabizade VV; Zavertkina MV; Erofeev A; Gorelkin P; Majouga AG; Zyk NV; Khazanova ES; Beloglazkina EK
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557929
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor.
Wu JB; Shi C; Chu GC; Xu Q; Zhang Y; Li Q; Yu JS; Zhau HE; Chung LW
Biomaterials; 2015 Oct; 67():1-10. PubMed ID: 26197410
[TBL] [Abstract][Full Text] [Related]
14. Novel α(2)β(1) integrin-targeted peptide probes for prostate cancer imaging.
Huang CW; Li Z; Cai H; Shahinian T; Conti PS
Mol Imaging; 2011 Aug; 10(4):284-94. PubMed ID: 21486537
[TBL] [Abstract][Full Text] [Related]
15. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging.
Zhang C; Liu T; Su Y; Luo S; Zhu Y; Tan X; Fan S; Zhang L; Zhou Y; Cheng T; Shi C
Biomaterials; 2010 Sep; 31(25):6612-7. PubMed ID: 20542559
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from androgen receptor signaling by modulation of oncogenic and apoptotic pathways.
Grossebrummel H; Peter T; Mandelkow R; Weiss M; Muzzio D; Zimmermann U; Walther R; Jensen F; Knabbe C; Zygmunt M; Burchardt M; Stope MB
Int J Oncol; 2016 Feb; 48(2):793-800. PubMed ID: 26648519
[TBL] [Abstract][Full Text] [Related]
17. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
[TBL] [Abstract][Full Text] [Related]
18. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
20. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.
Hadaschik BA; Ettinger S; Sowery RD; Zoubeidi A; Andersen RJ; Roberge M; Gleave ME
Int J Cancer; 2008 May; 122(10):2368-76. PubMed ID: 18240145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
